Triterras Inc (TRIT) Quote

NICKEL🚀👀

Hence the horse (DCVax) before the CarT (or Checkpoint Inhibitor), just a lucky guess at the time of picking a board handle that combo treatments might be more efficacious, well before combo research was surfaced :-)

Imo there’s much more to come and discover as is the case with scien

I have my platforms set up to my preference, with one platform on each monitor and charts on the ultra-wide. I use four monitors in total. Hovering and clicking works better for me than hotkeys since I’m using three platforms at the same time. What matters most is adjusting share size based on the p

RMB, I don't have access to a signed contract between CVS and a generic manufacturer. I would be surprised if anyone could find that. It is possible that multiple generic companies could have engaged in a form of collective bargaining. That is beyond the scope of my knowledge. My point still stands.

Citigroup told to get its house in order before it will be allowed to expand into China

"Citigroup Inc.’s expansion plan in China has hit a roadblock with US regulators after the Federal Reserve imposed a penalty on the bank for its data management and risk controls, according to p

CEO Lebby: https://www.youtube.com/watch?v=kOtNEz3-2JU

Whoops

UPB in da HIZZLE

GM FOLKSSSS

Please send me the names also, thanks

I took a starter in June, then sat on the bid the rest of the time trying to get a fill but no shares ever hit the bid. Then someone started jumping my bid out of the blue, a few days before the 1-SA was filed, so I figured something was up. I might have added a few more in the .40s when I saw the 1

While very interesting and I could see it being very true with ballas's track record, why would you come to an almost dead message board to post this? I'm sure there are more legal avenues to pursue this claim and I also think speaking about it while such a claim is going on could hurt your case. Un

Yep, thats why we got out, those new shares will be shorted to the full extent an everyday traders will not be able to get their hands on them either.

Citigroup is fined an additional $135 Million fine, on top of the $400 Million it was fined in 2020, for its risk issues.

"Banking regulators rejected Citi’s “living will” in June. That document was supposed to show how Citigroup could be wound down safely and orderly in case of fail

Sore I see!!

You need a work break lol!!

Can’t wait to go back to work and get a break from working on trees. My arms and knees are so sore this morning

Laxmi did your boy finally pay this or do you need us to send you more money?

https://adviserinfo.sec.gov/individual/summary/7701837

Oh wait, RD says he is getting over a million shortly. He can pay your bills.

"A Former Exec at Citibank Raises Alarm Bells in Federal Court Over Failed Risk
Controls Inside the Bank"

From the
@WigdorLaw
federal lawsuit filed by former Citigroup Managing Director Kathleen Martin:

"...in late 2021, Citi hired Martin, a data

If you look at the LinkedIn profile of Michael Shafie, ERHC's geophysicist, you'll see that he left ERHC in 2012, back when ERHC was struggling with money and went to work for Shell International E&P for a year, and then came back to work for ERHC Energy, and obviously ERHC had the revenue to cover

"Ticker Symbol: You" new clip about Poet
posted on Sep 22, 2024 11:53AM

https://youtu.be/pybd_1CsXJY?si=LR2V58SuHuTvsOWJ


from agoracom
https://agoracom.com/ir/POETTechnologies/forums/discussion/topics/804742-ticker-symbol-you-new-clip/messages/

Yeah on the down side that is

spoof

https://www.wsj.com/business/airlines/electronic-warfare-spooks-airlines-pilots-and-air-safety-officials-60959bbd?mod=hp_lead_pos1

I don't trade warrants, calls, or puts. I focus on scalping and shorting stocks. I'm trying to get back into swing trading, but scalping has become addictive for me. My main broker, CenterPoint Securities, should support that.

BofA says challenges 'overwhelm' potential benefits of Intel buyout
BofA analysts says a possible Qualcomm (QCOM) takeover of Intel (INTC) is "intriguing but perhaps impractical." The scale benefits are outweighed by regulatory and financial hurdles, the analysts tell investors in a research

gm!!!